Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Serum hepcidin levels are associated with obesity but not liver disease.

Vuppalanchi R, Troutt JS, Konrad RJ, Ghabril M, Saxena R, Bell LN, Kowdley KV, Chalasani N.

Obesity (Silver Spring). 2014 Mar;22(3):836-41. doi: 10.1002/oby.20403. Epub 2013 Dec 17.

2.

Iron deficiency in patients with nonalcoholic Fatty liver disease is associated with obesity, female gender, and low serum hepcidin.

Siddique A, Nelson JE, Aouizerat B, Yeh MM, Kowdley KV; NASH Clinical Research Network.

Clin Gastroenterol Hepatol. 2014 Jul;12(7):1170-8. doi: 10.1016/j.cgh.2013.11.017. Epub 2013 Nov 20.

3.

The Relationship of Serum Hemojuvelin and Hepcidin Levels with Iron Overload in Nonalcoholic Fatty Liver Disease.

Boga S, Alkim H, Alkim C, Koksal AR, Bayram M, Yilmaz Ozguven MB, Tekin Neijmann S.

J Gastrointestin Liver Dis. 2015 Sep;24(3):293-300. doi: 10.15403/jgld.2014.1121.243.hak.

4.

Plasma visfatin levels and gene expression in morbidly obese women with associated fatty liver disease.

Auguet T, Terra X, Porras JA, Orellana-Gavaldà JM, Martinez S, Aguilar C, Lucas A, Pellitero S, Hernández M, Del Castillo D, Richart C.

Clin Biochem. 2013 Feb;46(3):202-8. doi: 10.1016/j.clinbiochem.2012.11.006. Epub 2012 Nov 19.

PMID:
23174488
5.

Prevalence and Predictors of Non-Alcoholic Fatty Liver Disease in Morbidly Obese South Indian Patients Undergoing Bariatric Surgery.

Praveenraj P, Gomes RM, Kumar S, Karthikeyan P, Shankar A, Parthasarathi R, Senthilnathan P, Rajapandian S, Palanivelu C.

Obes Surg. 2015 Nov;25(11):2078-87. doi: 10.1007/s11695-015-1655-1.

PMID:
25835982
6.

Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients.

Lassailly G, Caiazzo R, Buob D, Pigeyre M, Verkindt H, Labreuche J, Raverdy V, Leteurtre E, Dharancy S, Louvet A, Romon M, Duhamel A, Pattou F, Mathurin P.

Gastroenterology. 2015 Aug;149(2):379-88; quiz e15-6. doi: 10.1053/j.gastro.2015.04.014. Epub 2015 Apr 25.

PMID:
25917783
8.

Adipokine serum levels are related to liver histology in severely obese patients undergoing bariatric surgery.

Argentou M, Tiniakos DG, Karanikolas M, Melachrinou M, Makri MG, Kittas C, Kalfarentzos F.

Obes Surg. 2009 Sep;19(9):1313-23. doi: 10.1007/s11695-009-9912-9. Epub 2009 Jul 15.

PMID:
19693638
9.

Hepcidin levels in children with chronic liver disease.

Cakir M, Erduran E, Turkmen ES, Aliyazicioglu Y, Reis GP, Cobanoglu U, Demir S.

Saudi J Gastroenterol. 2015 Sep-Oct;21(5):300-5. doi: 10.4103/1319-3767.166205.

10.

Decreased serum hepcidin and improved functional iron status 6 months after restrictive bariatric surgery.

Tussing-Humphreys LM, Nemeth E, Fantuzzi G, Freels S, Holterman AX, Galvani C, Ayloo S, Vitello J, Braunschweig C.

Obesity (Silver Spring). 2010 Oct;18(10):2010-6. doi: 10.1038/oby.2009.490. Epub 2010 Jan 14.

11.

Prevalence of Non-alcoholic Fatty Liver Disease and Steatohepatitis Risk Factors in Patients Undergoing Bariatric Surgery.

Morita S, Neto Dde S, Morita FH, Morita NK, Lobo SM.

Obes Surg. 2015 Dec;25(12):2335-43. doi: 10.1007/s11695-015-1696-5.

PMID:
25920616
12.

Association between ferritin and hepcidin levels and inflammatory status in patients with type 2 diabetes mellitus and obesity.

Andrews M, Soto N, Arredondo-Olguín M.

Nutrition. 2015 Jan;31(1):51-7. doi: 10.1016/j.nut.2014.04.019. Epub 2014 May 10.

PMID:
25441587
13.

Serum hepcidin levels and iron metabolism in obese children with and without fatty liver: case-control study.

Demircioğlu F, Görünmez G, Dağıstan E, Göksügür SB, Bekdaş M, Tosun M, Kızıldağ B, Kısmet E.

Eur J Pediatr. 2014 Jul;173(7):947-51. doi: 10.1007/s00431-014-2268-8. Epub 2014 Feb 7.

PMID:
24500395
14.

Suppressed cytokine production in whole blood cultures may be related to iron status and hepcidin and is partially corrected following weight reduction in morbidly obese pre-menopausal women.

Tussing-Humphreys L, Pini M, Ponemone V, Braunschweig C, Fantuzzi G.

Cytokine. 2011 Feb;53(2):201-6. doi: 10.1016/j.cyto.2010.11.008. Epub 2010 Dec 8.

15.

Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery.

Sell H, Divoux A, Poitou C, Basdevant A, Bouillot JL, Bedossa P, Tordjman J, Eckel J, Clément K.

J Clin Endocrinol Metab. 2010 Jun;95(6):2892-6. doi: 10.1210/jc.2009-2374. Epub 2010 Apr 7.

PMID:
20375212
16.

Plasminogen activator inhibitor type 1 serum levels and 4G/5G gene polymorphism in morbidly obese Hispanic patients with non-alcoholic fatty liver disease.

Espino A, Villagrán A, Vollrath V, Hanckes P, Salas R, Farah A, Solís N, Pizarro M, Escalona A, Boza C, Pérez G, Carrasco G, Padilla O, Miquel JF, Nervi F, Chavez-Tapia NC, Arab JP, Alvarez-Lobos M, Arrese M, Riquelme A.

Ann Hepatol. 2011 Oct-Dec;10(4):493-501.

17.

Lower serum hepcidin and greater parenchymal iron in nonalcoholic fatty liver disease patients with C282Y HFE mutations.

Nelson JE, Brunt EM, Kowdley KV; Nonalcoholic Steatohepatitis Clinical Research Network.

Hepatology. 2012 Nov;56(5):1730-40. doi: 10.1002/hep.25856. Epub 2012 Sep 20.

18.

Low Serum Hepcidin in Patients with Autoimmune Liver Diseases.

Lyberopoulou A, Chachami G, Gatselis NK, Kyratzopoulou E, Saitis A, Gabeta S, Eliades P, Paraskeva E, Zachou K, Koukoulis GK, Mamalaki A, Dalekos GN, Simos G.

PLoS One. 2015 Aug 13;10(8):e0135486. doi: 10.1371/journal.pone.0135486. eCollection 2015.

19.

Serum prohepcidin levels in chronic hepatitis C, alcoholic liver disease, and nonalcoholic fatty liver disease.

Lee SH, Jeong SH, Park YS, Hwang JH, Kim JW, Kim N, Lee DH.

Korean J Hepatol. 2010 Sep;16(3):288-94. doi: 10.3350/kjhep.2010.16.3.288.

20.

Serum folate and homocysteine levels in obese females with non-alcoholic fatty liver.

Hirsch S, Poniachick J, Avendaño M, Csendes A, Burdiles P, Smok G, Diaz JC, de la Maza MP.

Nutrition. 2005 Feb;21(2):137-41.

PMID:
15723740

Supplemental Content

Support Center